Dual-targeted therapy shows promise against metastatic triple-negative breast cancer

The Medical News ·
Health & Medicine United Kingdom

A new preclinical study suggests that attacking triple-negative breast cancer (TNBC) in two ways at once can kill cancer cells, slow tumor growth and limit the cancer's spread. Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) developed the approach.

Read original article on The Medical News →

Related news